Anti‐CD19 CAR T as a feasible therapy for refractory/relapsed mixed phenotype acute leukemia patients. Issue 10 (4th April 2022) - Li, Xiangqun; Chen, Kylan; Zhang, Hailong; Zhang, Xian; Yang, Junfang; Liu, Jing; Zheng, Jianwei; Dong, Fei; Zhu, Yongbo; Yu, Jiao; Zhang, Haihong; Lu, Peihua; et al.